Affiliation:
1. Department of Chemical Theory of Drugs, Faculty of Pharmacy , Comenius University , Bratislava
2. Institute of Analytical Chemistry, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava
Abstract
Abstract
The present work describes the synthesis, physico-chemical characteristics, antioxidative properties, and high-performance liquid chromatography (HPLC) enantioseparation of novel, potentially bioactive aryloxyaminopropanols – derivatives of naphthalen-2-ol modified in the basic part of their molecules. Reaction of naphthalene-2-ol with chloromethyloxirane leads to 2-[(naphthalen-2-yloxy)methyl]oxirane, which reacts in the next step with branched aliphatic amines (isopropylamine, tert-butylamine, and dimethylamine), aromatic amines (aniline, 3,4-dimethoxyphenylethylamine), and heterocyclic amines (pyrrolidine, imidazole, 2-methylimidazole, piperidine, morpholine, 4-methylpiperidine, or 2-methoxyphenylpiperidine). The target compounds were isolated in the form of free bases, as well as their salts with fumaric or hydrochloric acid. Their purity was established by thin-layer chromatography and their IR, UV, 1H-NMR, and 13C-NMR spectra were recorded. The antioxidant activities of prepared compounds were measured by the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) method and they were compared with the values for the corresponding salts. Enantioseparation was accomplished by means of enantioselective HPLC using amylose tris(3,5-dimethylphenyl)carbamate (Chiralpak AD), as well as Chirobiotic T (native teicoplanin) in some cases.
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference40 articles.
1. Baker JG, Hill SJ, Summera RJ. Evolution of β-blocker from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol Sci. 2011;32(4):227–234.
2. Tobe SW. β-adrenergic receptor blockers in hypertension. Can J Cardiol. 2014;30(5):S1–S2.
3. Akbar S, Alorainy MS. The current status of beta blockers’ use in the management of hypertension. Saudi Med J. 2014;35(11):1307–1317.
4. Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S. Beta-blockers as antiarrhythmic agents. In: Kass RS, Clancy CE, eds. Handbook of Experimental Pharmacology Vol. 171. Heidelberg: Springer-Verlag; 2006.
5. Cruickshank JM. Beta-blockers and heart failure. Indian Heart J. 2010;62(2):101–110.